Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)

Joly, P.; Horvath, B.; Patsatsi, Α; Uzun, S.; Bech, R.; Beissert, S.; Bergman, R.; Bernard, P.; Borradori, L.; Caproni, M.; Caux, F.; Cianchini, G.; Daneshpazhooh, M.; De, D; Dmochowski, M.; Drenovska, K.; Ehrchen, J.; Feliciani, C.; Goebeler, M.; Groves, R.; Guenther, C.; Hofmann, S.; Ioannides, D.; Kowalewski, C.; Ludwig, R.; Lim, Y.L.; Marinovic, B.; Marzano, A.V.; Mascaró, J.M.; Mimouni, D.; Murrell, D.F.; Pincelli, C.; Squarcioni, C.P.; Sárdy, M.; Setterfield, J.; Sprecher, E.; Vassileva, S.; Wozniak, K.; Yayli, S.; Zambruno, G.; Zillikens, D.; Hertl, M.; Schmidt, E.

doi:10.1111/jdv.16752

Public

Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)

Shared by NobleBlocks on Aug 24, 2020 • 12:00 AM UTC

Authors:

P. Joly

B. Horvath

Α Patsatsi

Abstract

Abstract Background Pemphigus encompasses a group of life‐threatening autoimmune bullous diseases characterized by blisters and erosions of the mucous membranes and skin. Before the era of immunosuppressive treatment, pemphigus was almost always fatal. Due to its rarity, only few randomized controll...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!